COMMUNIQUÉS West-GlobeNewswire

Oncolytics Biotech® Announces Type C FDA Meeting to Discuss Single-arm Registrational Pathway for Pelareorep in Anal Cancer
06/04/2026
SAN DIEGO, April 06, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, an investigational, systemically [...]
Akari Therapeutics Announces Strategic Partnership with WuXi XDC to Advance Development of Its Novel ADC Payload Targeting RNA Splicing
06/04/2026
Strategic Partnership Enables Akari to Accelerate IND Filing By Late 2026 TAMPA, Fla. and LONDON, April 06, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing [...]
Axe Compute Names Kyle Okamoto President, Adding Deep Infrastructure Systems Expertise to Executive Team
06/04/2026
Okamoto, who helped scale Aethir's decentralized GPU network to 200+ global locations, will lead enterprise growth strategy and execution at Axe Compute PITTSBURGH, April 06, 2026 (GLOBE NEWSWIRE) -- Axe Compute (Nasdaq [...]
Flare Therapeutics Announces Three Upcoming Poster Presentations at AACR Annual Meeting 2026
06/04/2026
CAMBRIDGE, Mass., April 06, 2026 (GLOBE NEWSWIRE) -- Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other [...]
Stereotaxis Announces FDA Clearance and Launch of Synchrony System
06/04/2026
ST. LOUIS, April 06, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has received U.S. Food [...]
Sienna Senior Living recognized by The Globe and Mail’s Women Lead Here Benchmark
06/04/2026
MARKHAM, Ontario, April 06, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living, one of Canada’s leading owners and operators of senior living communities, has been recognized for the sixth consecutive year in The Globe and [...]
Adaptin Bio Shares to be Quoted on the OTCQB Under Ticker Symbol APTN
06/04/2026
CHARLOTTE, N.C., April 06, 2026 (GLOBE NEWSWIRE) -- Adaptin Bio, Inc. (OTCQB: APTN), (“Adaptin” or the “Company”), a biotechnology company developing precision cancer therapeutics enabled by targeted delivery to the [...]
Scienture Provides Annual Shareholder Update, Outlining Significant Progress and Strategic Priorities for the Year Ahead
06/04/2026
COMMACK, NY, April 06, 2026 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (“Scienture”) a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to [...]
Avalyn Appoints Jon Congleton, Seasoned Biopharmaceutical Executive, to its Board of Directors
06/04/2026
BOSTON, April 06, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., (“Avalyn” or the “Company”), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare [...]
Geron to Participate in the 25th Annual Needham Virtual Healthcare Conference
06/04/2026
FOSTER CITY, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that [...]
Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure
06/04/2026
Jilin, China, April 06, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research, development, manufacturing [...]
TOMI Environmental Solutions, Inc. Announces Surge in SteraMist Adoption Across Compounding Pharmacy Industry Amid Tightening Regulatory Standards
06/04/2026
SteraMist iHP Expansion into Compounding 503A and 503B Pharmacies FREDERICK, Md., April 06, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and [...]
Stipple Bio Emerges From Stealth with Oversubscribed $100 Million Series A Financing to Advance STP-100 into Early Clinical Studies and Advance a Precision Oncology Pipeline that Leverages its Pointillist Platform
06/04/2026
– Series A financing co-led by RA Capital, a16z Bio+Health and Nextech Invest, and includes participation from existing investors Emerson Collective Investments (managed by Yosemite), GV (Google Ventures), LoLa Capital [...]
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/04/2026
NEW HAVEN, Conn., April 06, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that on April 1, 2026, Invivyd granted 16 newly hired non-executive employees options to purchase an aggregate of 1,083, [...]
Neumora Therapeutics to Participate in 25th Annual Needham Virtual Healthcare Conference
06/04/2026
WATERTOWN, Mass., April 06, 2026 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of programs that target novel mechanisms [...]
BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer
06/04/2026
— Experienced R&D leader with a track record of advancing innovative therapies from early development to global approval — RESEARCH TRIANGLE PARK, N.C., April 06, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, [...]
Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
06/04/2026
SAN MATEO, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic [...]
Sharps Technology Reports 2025 Year-End Results and Highlights Continued Execution of Solana Treasury Strategy
06/04/2026
Over 2 Million SOL Held with Approximately 95% Staked at ~7% Gross Annualized Yield Total Assets of $269.1 Million, Up from $7.3 Million at Year-End 2024 Expanded Solana Ecosystem Partnerships Including Coinbase, Crypto [...]
NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx’s Preservative-Free Ketamine Application
06/04/2026
NRx has received a letter from the FDA Office of Generic Drugs indicating preliminary alignment on labeling for NRx’s preservative-free ketamine product. Labeling remains subject to final supervisory review. NRx [...]

Pages